Try the Demo today!
| SEC Filing | Insider | Company | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Return |
|---|---|---|---|---|---|---|---|---|---|
| 30-Sep-21 4:41 PM View:  | Markvicka Taunia Chief Operating Officer Director | Cleveland BioLabs, Inc. (CBLI) | 28-Sep-21 | Grant | 100,000 | -- | -- | 100% 0 to 100.0K | |
| 28-Oct-21 4:08 PM View: | Saluck Randy S. Director | Cleveland BioLabs, Inc. (CBLI) | 09-Sep-21 | Grant | 60,000 | -- | -- | 42857% 0.14K to 60.14K | |
| 19-Oct-21 4:05 PM View: | Verny Lea Director | Cleveland BioLabs, Inc. (CBLI) | 09-Sep-21 | Grant | 60,000 | -- | -- | 100% 0 to 60.0K | |
| 19-Oct-21 4:05 PM View: | Barbarick Steve K Director | Cleveland BioLabs, Inc. (CBLI) | 09-Sep-21 | Grant | 60,000 | -- | -- | 100% 0 to 60.0K | |
| 29-Jul-21 9:33 PM View: | Aronstam Peter Chief Financial Officer | Cleveland BioLabs, Inc. (CBLI) | 27-Jul-21 | Grant | 141,370 | -- | -- | 100% 0 to 141.37K | |
| 29-Jul-21 9:34 PM View: | Selsky Clifford Chief Medical Officer | Cleveland BioLabs, Inc. (CBLI) | 27-Jul-21 | Grant | 101,579 | -- | -- | 100% 0 to 101.58K | |
| 29-Jul-21 9:33 PM View: | McAvoy Cozette M. Chief Legal Officer | Cleveland BioLabs, Inc. (CBLI) | 27-Jul-21 | Grant | 60,947 | -- | -- | 100% 0 to 60.95K | |
| 04-Aug-21 7:00 PM View: | Handley Michael K President and CEO Director | Cleveland BioLabs, Inc. (CBLI) | 27-Jul-21 | Grant | 296,609 | -- | -- | 100% 0 to 296.61K | |
| 23-Jul-21 4:22 PM View: | Miller Langdon L Chief Medical Officer | Cleveland BioLabs, Inc. (CBLI) | 22-Jul-21 | Option Exercise | 10,000 | $3.00 | $30,000.00 | 100% 0 to 10.0K | |
| 27-Feb-15 6:59 PM View: | Saluck Randy S. Director | Cleveland BioLabs, Inc. (CBLI) | 25-Feb-15 | Market Purchase | 1,891 | $3.42 | $6,468.17 | 45% 4.22K to 6.12K | (4%) |
| 12-Jan-15 4:20 PM View: | Brown Julia R Director | Cleveland BioLabs, Inc. (CBLI) | 08-Jan-15 | Grant | 62,500 | $0.30 | $18,750.00 | 116% 53.98K to 116.48K | (46%) |
| 12-Jan-15 4:15 PM View: | Principi Anthony Director | Cleveland BioLabs, Inc. (CBLI) | 08-Jan-15 | Grant | 37,947 | $0.30 | $11,384.10 | 262% 14.47K to 52.42K | (46%) |
| 17-Feb-15 7:25 PM View: | Brown Julia R Director | Cleveland BioLabs, Inc. (CBLI) | 01-Oct-14 | Grant | 1,903 | $9.20 | $17,507.60 | 239% 0.8K to 2.7K | |
| 17-Mar-14 5:36 PM View: | Hohn David C Director | Cleveland BioLabs, Inc. (CBLI) | 13-Mar-14 | Grant | 22,978 | $0.68 | $15,625.00 | 114% 20.07K to 43.05K | (77%) |
| 21-Jun-13 8:33 PM View: | Brown Julia R Director | Cleveland BioLabs, Inc. (CBLI) | 19-Jun-13 | Grant | 15,939 | -- | -- | 100% 0 to 15.94K | |
| 21-Jun-13 8:34 PM View: | Principi Anthony Director | Cleveland BioLabs, Inc. (CBLI) | 19-Jun-13 | Grant | 14,472 | -- | -- | 100% 0 to 14.47K | |
| 21-Jun-13 8:33 PM View: | Hohn David C Director | Cleveland BioLabs, Inc. (CBLI) | 19-Jun-13 | Grant | 10,487 | -- | -- | 109% 9.58K to 20.07K | |
| 21-Jun-13 8:33 PM View: | Dicorleto Paul E Director | Cleveland BioLabs, Inc. (CBLI) | 19-Jun-13 | Grant | 10,102 | -- | -- | 32% 31.87K to 41.97K | |
| 23-May-13 7:34 PM View: | Dicorleto Paul E Director | Cleveland BioLabs, Inc. (CBLI) | 21-May-13 | Market Purchase | 6,210 | $1.61 | $9,997.48 | 24% 25.66K to 31.87K | (90%) |
| 21-May-13 9:02 PM View: | Saluck Randy S. Director | Cleveland BioLabs, Inc. (CBLI) | 17-May-13 | Market Purchase | 3,500 | $1.60 | $5,613.30 | 4% 81.0K to 84.5K | (90%) |
| 18-Mar-13 2:13 PM View: | Antal James Director | Cleveland BioLabs, Inc. (CBLI) | 15-Mar-13 | Market Purchase | 3,700 | $1.56 | $5,772.00 | 12% 31.56K to 35.26K | (90%) |
| 14-Feb-13 8:29 PM View: | Antal James Director | Cleveland BioLabs, Inc. (CBLI) | 27-Dec-12 | Market Purchase | 4,300 | $1.35 | $5,805.00 | 16% 27.26K to 31.56K | (89%) |
| 14-Feb-13 8:29 PM View: | Kogan Yakov Chief Executive Officer Director | Cleveland BioLabs, Inc. (CBLI) | 17-Dec-12 | Gift | 27,482 | -- | -- | 4% 689.36K to 716.84K | |
| 14-Feb-13 8:29 PM View: | Kogan Yakov Chief Executive Officer Director | Cleveland BioLabs, Inc. (CBLI) | 17-Dec-12 | Gift | 27,482 | -- | -- | (4%) 716.84K to 689.36K | |
| 25-Sep-12 6:01 AM View: | Antal James Director | Cleveland BioLabs, Inc. (CBLI) | 21-Sep-12 | Market Purchase | 2,316 | $2.60 | $6,021.60 | 9% 24.94K to 27.26K | (94%) |
| 05-Jul-12 6:00 AM View: | Hohn David C Director | Cleveland BioLabs, Inc. (CBLI) | 02-Jul-12 | Market Purchase | 1,000 | $1.61 | $1,610.00 | 12% 8.58K to 9.58K | (90%) |
| 28-Jun-12 9:35 PM View: | Kogan Yakov Chief Executive Officer Director | Cleveland BioLabs, Inc. (CBLI) | 26-Jun-12 | Grant | 15,665 | -- | -- | 2% 673.69K to 689.36K | |
| 28-Jun-12 9:35 PM View: | Hohn David C Director | Cleveland BioLabs, Inc. (CBLI) | 26-Jun-12 | Grant | 5,584 | -- | -- | 186% 3.0K to 8.58K | |
| 28-Jun-12 9:35 PM View: | Fonstein Michael President Director | Cleveland BioLabs, Inc. (CBLI) | 26-Jun-12 | Grant | 8,065 | -- | -- | < 1% 1.17M to 1.18M | |
| 28-Jun-12 9:35 PM View: | Kasten Bernard L Director | Cleveland BioLabs, Inc. (CBLI) | 26-Jun-12 | Grant | 6,342 | -- | -- | 31% 20.66K to 27.0K | |
| 28-Jun-12 9:35 PM View: | Lyons C Neil Chief Financial Officer | Cleveland BioLabs, Inc. (CBLI) | 26-Jun-12 | Grant | 20,273 | -- | -- | 100% 0 to 20.27K | |
| 28-Jun-12 9:35 PM View: | Gudkov Andrei V Chief Scientific Officer Director | Cleveland BioLabs, Inc. (CBLI) | 26-Jun-12 | Grant | 12,770 | -- | -- | < 1% 1.5M to 1.52M | |
| 28-Jun-12 9:35 PM View: | Kogan Yakov Chief Executive Officer Director | Cleveland BioLabs, Inc. (CBLI) | 26-Jun-12 | Grant | 27,482 | -- | -- | 4% 646.21K to 673.69K | |
| 03-Jul-12 5:21 PM View: | Antal James Director | Cleveland BioLabs, Inc. (CBLI) | 15-Jun-12 | Market Purchase | 3,400 | $1.76 | $5,984.00 | 16% 21.54K to 24.94K | (91%) |
| 06-Apr-12 6:10 AM View: | Hohn David C Director | Cleveland BioLabs, Inc. (CBLI) | 04-Apr-12 | Market Purchase | 1,000 | $1.71 | $1,710.00 | 50% 2.0K to 3.0K | (91%) |
| 20-Mar-12 9:46 PM View: | Fonstein Michael President Director | Cleveland BioLabs, Inc. (CBLI) | 20-Mar-12 | Market Sale | 20,000 | $2.94 | $58,896.00 | (2%) 1.19M to 1.17M | 95% |
| 20-Mar-12 9:46 PM View: | Fonstein Michael President Director | Cleveland BioLabs, Inc. (CBLI) | 19-Mar-12 | Market Sale | 35,601 | $3.04 | $108,241.00 | (3%) 1.22M to 1.19M | 95% |
| 03-Jul-12 5:21 PM View: | Antal James Director | Cleveland BioLabs, Inc. (CBLI) | 16-Mar-12 | Market Purchase | 1,900 | $3.16 | $5,995.00 | 10% 19.64K to 21.54K | (95%) |
| 20-Mar-12 9:46 PM View: | Fonstein Michael President Director | Cleveland BioLabs, Inc. (CBLI) | 16-Mar-12 | Market Sale | 44,399 | $3.12 | $138,636.00 | (4%) 1.27M to 1.22M | 95% |
| 05-Jan-12 4:48 PM View: | Hohn David C Director | Cleveland BioLabs, Inc. (CBLI) | 04-Jan-12 | Market Purchase | 1,000 | $2.98 | $2,980.00 | 100% 1.0K to 2.0K | (95%) |
| 20-Dec-11 4:49 PM View: | Antal James Director | Cleveland BioLabs, Inc. (CBLI) | 16-Dec-11 | Market Purchase | 2,105 | $2.79 | $5,865.52 | 12% 17.54K to 19.64K | (94%) |
| 08-Nov-11 8:37 PM View: | Kogan Yakov COO, Secretary Director | Cleveland BioLabs, Inc. (CBLI) | 07-Nov-11 | Grant | 1,638 | -- | -- | < 1% 644.5K to 646.14K | |
| 06-Oct-11 7:43 AM View: | Hohn David C Director | Cleveland BioLabs, Inc. (CBLI) | 04-Oct-11 | Market Purchase | 1,000 | $2.36 | $2,360.00 | 100% 0 to 1.0K | (93%) |
| 20-Sep-11 9:07 AM View: | Antal James Director | Cleveland BioLabs, Inc. (CBLI) | 16-Sep-11 | Market Purchase | 1,881 | $3.18 | $5,987.41 | 12% 15.66K to 17.54K | (95%) |
| 07-Sep-11 6:08 AM View: | Fonstein Michael CEO and President Director | Cleveland BioLabs, Inc. (CBLI) | 02-Sep-11 | Market Purchase | 2,200 | $2.27 | $4,994.00 | < 1% 1.25M to 1.25M | (93%) |
| 22-Aug-11 6:12 AM View: | Kogan Yakov COO, Secretary Director | Cleveland BioLabs, Inc. (CBLI) | 19-Aug-11 | Market Purchase | 1,300 | $2.29 | $2,976.35 | < 1% 643.2K to 644.5K | (93%) |
| 15-Aug-11 3:43 PM View: | Kasten Bernard L Director | Cleveland BioLabs, Inc. (CBLI) | 15-Aug-11 | Market Purchase | 5,000 | $2.60 | $13,000.00 | 1% 445.31K to 450.31K | (94%) |
| 15-Aug-11 3:45 PM View: | Dicorleto Paul E Director | Cleveland BioLabs, Inc. (CBLI) | 15-Aug-11 | Market Purchase | 10,000 | $2.60 | $26,000.00 | 5% 205.66K to 215.66K | (94%) |
| 15-Aug-11 3:43 PM View: | Kasten Bernard L Director | Cleveland BioLabs, Inc. (CBLI) | 15-Aug-11 | Market Purchase | 5,000 | $2.58 | $12,900.00 | 1% 440.31K to 445.31K | (94%) |
| 22-Nov-10 5:28 PM View: | Kasten Bernard L Director | Cleveland BioLabs, Inc. (CBLI) | 19-Nov-10 | Market Purchase | 10,000 | $6.15 | $61,500.00 | 28% 35.31K to 45.31K | (98%) |
